Switch to:
More From Other Websites
NEURALSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 21 2016
Neuralstem Achieves 50% Enrollment in NSI-189 Phase 2 Trial in Major Depressive Disorder Sep 21 2016
Neuralstem Achieves 50% Enrollment in NSI-189 Phase 2 Trial in Major Depressive Disorder Sep 21 2016
ETF’s with exposure to Neuralstem, Inc. : September 13, 2016 Sep 13 2016
NEURALSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 12 2016
Neuralstem Presented NSI-189 Preclinical Data in Type 1 and Type 2 Diabetes at the Annual Meeting of... Sep 12 2016
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group Sep 12 2016
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group Sep 12 2016
NEURALSTEM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Sep 01 2016
ETF’s with exposure to Neuralstem, Inc. : August 30, 2016 Aug 30 2016
Coverage initiated on Neuralstem by ROTH Capital Aug 29 2016
NEURALSTEM, INC. Financials Aug 19 2016
ETF’s with exposure to Neuralstem, Inc. : August 19, 2016 Aug 19 2016
Neuralstem, Inc. :CUR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 Aug 18 2016
curasan accelerates sales growth in the first six months due to rising foreign demand Aug 18 2016
Neuralstem reports 2Q loss Aug 11 2016
Neuralstem reports 2Q loss Aug 11 2016
Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates Aug 11 2016
NEURALSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 11 2016
Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates Aug 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK